BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12816214)

  • 1. Otoacoustic emissions in patients with hypotension.
    Balatsouras DG; Korres S; Simaskos N; Kandiloros D; Ferekidis E; Economou C
    J Laryngol Otol; 2003 Apr; 117(4):265-9. PubMed ID: 12816214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the correspondence between pure tone and distorsion product otoacoustic emissions audiometrics: basis for an objective cochlear audiometrics model].
    Jürgens A; Buisan A; Canela M; Abelló P
    Acta Otorrinolaringol Esp; 1999 May; 50(4):253-9. PubMed ID: 10431072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Examinations of distortion product otoacoustic emission in hereditary progressive non-syndromic hearing loss].
    Ke X; Yu H; Liu Y; Gu Z; Lu Y; Li L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):102-4. PubMed ID: 12768663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet's disease.
    Dagli M; Eryilmaz A; Tanrikulu S; Aydin A; Gonul M; Gul U; Gocer C
    Auris Nasus Larynx; 2008 Sep; 35(3):333-7. PubMed ID: 17996415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of cochlear function with distortion products of otoacoustic emissions in acoustic neuroma].
    Oeken J
    HNO; 1996 Dec; 44(12):677-84. PubMed ID: 9081952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochlear function in facioscapulohumeral muscular dystrophy.
    Balatsouras DG; Korres S; Manta P; Panousopoulou A; Vassilopoulos D
    Otol Neurotol; 2007 Jan; 28(1):7-10. PubMed ID: 17106430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer hair cell activity of the cochlea in patients with iron deficiency anemia.
    Cetin T; Yetiser S; Cekin E; Durmus C; Nevruz O; Oktenli C
    Auris Nasus Larynx; 2004 Dec; 31(4):389-94. PubMed ID: 15571912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of pure-tone thresholds in adults using extrapolated distortion product otoacoustic emission input/output-functions and auditory steady state responses.
    Hatzopoulos S; Ciorba A; Petruccelli J; Grasso D; Sliwa L; Kochanek K; Skarzynski H; Martini A
    Int J Audiol; 2009; 48(9):625-31. PubMed ID: 19925336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of noise-induced hearing loss with distortion product otoacoustic emissions.
    Balatsouras DG
    Med Sci Monit; 2004 May; 10(5):CR218-22. PubMed ID: 15114273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion-product otoacoustic emission spectra and high-resolution audiometry in noise-induced hearing loss.
    Avan P; Bonfils P
    Hear Res; 2005 Nov; 209(1-2):68-75. PubMed ID: 16112827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distortion product otoacoustic emissions: hit and false-positive rates in normal-hearing and hearing-impaired subjects.
    Musiek FE; Baran JA
    Am J Otol; 1997 Jul; 18(4):454-61. PubMed ID: 9233485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion product otoacoustic emissions in tinnitus patients.
    Onishi ET; Fukuda Y; Suzuki FA
    Int Tinnitus J; 2004; 10(1):13-6. PubMed ID: 15379342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Applying distortion product otoacoustic emission in testing human sensory hearing loss].
    Chen X; Zheng H; Zheng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):382-4. PubMed ID: 15181843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distortion product otoacoustic emission response characteristics in older adults.
    Torre P; Cruickshanks KJ; Nondahl DM; Wiley TL
    Ear Hear; 2003 Feb; 24(1):20-9. PubMed ID: 12598810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
    Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
    Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.